Search research articles
Contact Us
Filters
Showing results (1-10 of 44) with videos related to
Page
of 5
Sort By:
Methods in Molecular Medicine
|
May 25, 2005
Cell cycle and drug sensitivity
Aslamuzzaman Kazi, Q Ping Dou
The Journal of Biological Chemistry
|
February 1, 2020
The GTPase KRAS suppresses the p53 tumor suppressor by activating the NRF2-regulated antioxidant defense system in cancer cells
Hua Yang, Shengyan Xiang, Aslamuzzaman Kazi, et al.
Molecular Pharmacology
|
September 19, 2002
Inhibition of bcl-x(l) phosphorylation by tea polyphenols or epigallocatechin-3-gallate is associated with prostate cancer cell apoptosis
Aslamuzzaman Kazi, David M Smith, Qing Zhong, et al.
Frontiers in Bioscience : a Journal and Virtual Library
|
September 9, 2004
Isoflavones in breast cancer chemoprevention: where do we go from here?
Nagi Kumar, Kathryn Allen, Diane Riccardi, et al.
Biochimica Et Biophysica Acta
|
May 26, 2004
Direct inhibition of the ubiquitin-proteasome pathway by ester bond-containing green tea polyphenols is associated with increased expression of sterol regulatory element-binding protein 2 and LDL receptor
Deborah J Kuhn, Audrey C Burns, Aslamuzzaman Kazi, et al.
Current Cancer Drug Targets
|
November 25, 2005
Anti-angiogenic and anti-tumor properties of proteasome inhibitors
Kenyon G Daniel, Deborah J Kuhn, Aslamuzzaman Kazi, et al.
Progress in Cell Cycle Research
|
November 5, 2003
Interruption of tumor cell cycle progression through proteasome inhibition: implications for cancer therapy
Q Ping Dou, David M Smith, Kenyon G Daniel, et al.
Iscience
|
February 28, 2023
Novel mutant KRAS addiction signature predicts response to the combination of ERBB and MEK inhibitors in lung and pancreatic cancers
Katarzyna M Tyc, Aslamuzzaman Kazi, Alok Ranjan, et al.
The Journal of Biological Chemistry
|
February 27, 2014
Discovery of PI-1840, a novel noncovalent and rapidly reversible proteasome inhibitor with anti-tumor activity
Aslamuzzaman Kazi, Sevil Ozcan, Awet Tecleab, et al.
British Journal of Haematology
|
October 6, 2025
Geranylgeranyl transferase-1 inhibitor GGTI-2417 enhances the anti-tumour efficacy of histone deacetylase inhibitors in different T-cell lymphoma lines
Xiaoyan Hu, Lin Li, Jewel Nkwocha, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 44) with videos related to
Sort By:
Page
of 5
Methods in Molecular Medicine
|
May 25, 2005
Cell cycle and drug sensitivity
Aslamuzzaman Kazi, Q Ping Dou
The Journal of Biological Chemistry
|
February 1, 2020
The GTPase KRAS suppresses the p53 tumor suppressor by activating the NRF2-regulated antioxidant defense system in cancer cells
Hua Yang, Shengyan Xiang, Aslamuzzaman Kazi, et al.
Molecular Pharmacology
|
September 19, 2002
Inhibition of bcl-x(l) phosphorylation by tea polyphenols or epigallocatechin-3-gallate is associated with prostate cancer cell apoptosis
Aslamuzzaman Kazi, David M Smith, Qing Zhong, et al.
Frontiers in Bioscience : a Journal and Virtual Library
|
September 9, 2004
Isoflavones in breast cancer chemoprevention: where do we go from here?
Nagi Kumar, Kathryn Allen, Diane Riccardi, et al.
Biochimica Et Biophysica Acta
|
May 26, 2004
Direct inhibition of the ubiquitin-proteasome pathway by ester bond-containing green tea polyphenols is associated with increased expression of sterol regulatory element-binding protein 2 and LDL receptor
Deborah J Kuhn, Audrey C Burns, Aslamuzzaman Kazi, et al.
Current Cancer Drug Targets
|
November 25, 2005
Anti-angiogenic and anti-tumor properties of proteasome inhibitors
Kenyon G Daniel, Deborah J Kuhn, Aslamuzzaman Kazi, et al.
Progress in Cell Cycle Research
|
November 5, 2003
Interruption of tumor cell cycle progression through proteasome inhibition: implications for cancer therapy
Q Ping Dou, David M Smith, Kenyon G Daniel, et al.
Iscience
|
February 28, 2023
Novel mutant KRAS addiction signature predicts response to the combination of ERBB and MEK inhibitors in lung and pancreatic cancers
Katarzyna M Tyc, Aslamuzzaman Kazi, Alok Ranjan, et al.
The Journal of Biological Chemistry
|
February 27, 2014
Discovery of PI-1840, a novel noncovalent and rapidly reversible proteasome inhibitor with anti-tumor activity
Aslamuzzaman Kazi, Sevil Ozcan, Awet Tecleab, et al.
British Journal of Haematology
|
October 6, 2025
Geranylgeranyl transferase-1 inhibitor GGTI-2417 enhances the anti-tumour efficacy of histone deacetylase inhibitors in different T-cell lymphoma lines
Xiaoyan Hu, Lin Li, Jewel Nkwocha, et al.
Page
of 5